Bristol-Myers Squibb Co (NYSE:BMY)
$ 44.94 0.2 (0.45%) Market Cap: 91.10 Bil Enterprise Value: 138.84 Bil PE Ratio: 0 PB Ratio: 5.52 GF Score: 83/100

Bristol-Myers Squibb Co at Morgan Stanley Global Healthcare Conference (Virtual) Transcript

Sep 14, 2021 / 12:00PM GMT
Release Date Price: $62.11 (-1.16%)
Matthew Kelsey Harrison
Morgan Stanley, Research Division - Executive Director

Great. Good morning, everybody, and thanks for joining us for the fourth day of our conference. I'm Matthew Harrison, one of the biotech analysts here at Morgan Stanley. And I'm very pleased to have Bristol with us for the next session.

Before we get started, I need to read a disclosure statement. Please note that all important disclosures, including personal holdings disclosures and Morgan Stanley disclosures, appear on the Morgan Stanley public website at morganstanley.com/researchdisclosures.

So I'm going to turn it over to Giovanni to make some opening comments, and then we'll get right into it.

Giovanni Caforio
Bristol-Myers Squibb Company - Chairman of the Board & CEO

Thank you, Matthew, and good morning, everyone. It's a great opportunity to be able to spend some time with all of you. Let me just say for Bristol-Myers Squibb, we are getting close actually to 2 years after the acquisition of Celgene, and it's a really good time to reflect on where we

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot